Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry is a **pseudogene related to the guanylate binding protein family**, annotated as "novel guanylate binding protein pseudogene" and identified by Ensembl as ENSG00000289712. Pseudogenes are typically non-functional gene copies that have lost their protein-coding ability due to mutations.[7] Some pseudogenes are transcribed and can regulate gene expression through RNA-based mechanisms such as acting as microRNA sponges or producing small interfering RNAs, thereby modulating the activity of their parent or related genes.[3][5] However, the majority do not produce functional proteins, and most are not directly implicated in drug action or disease processes. This particular pseudogene has no established therapeutic or biomarker role and is not considered a canonical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel guanylate binding protein pseudogene.